Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03902431 · ClinicalTrials.gov registry record · NA

Translating the ABCS Into HIV Care

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
4,277
Enrollment target

NCT03902431: Completed NA study, sponsored by University of Rochester.

NCT03902431 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 4,277 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (205% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03902431, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
4,277 participants
Enrollment target

Study Summary

The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.

Primary Outcome

This will be based on the ACVSD risk calculator

Interventions

  • BEHAVIORAL ABCS training

Trial Details

FieldValue
Enrollment Target 4,277 participants
Start Date 2019-09-26
Est. Completion 2024-05-31
Phase NA
University of Rochester

636 total trials

What the finished NCT03902431 record still lists

NCT03902431 is an interventional study that assigns participants to a tested intervention. Its 4,277 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (205% higher).

The record links to 0 conditions, and to 1 intervention - of which ABCS training is the first listed.

NCT03902431 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03902431 about?

NCT03902431 is a clinical study titled "Translating the ABCS Into HIV Care". The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)whic...

What is the current status of trial NCT03902431?

This trial is currently completed. It is a NA study. The enrollment target is 4,277 participants. The study started on 2019-09-26. Estimated completion is 2024-05-31.

What interventions are being tested in trial NCT03902431?

The interventions under investigation include: ABCS training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03902431?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03902431's enrollment target sits among peer trials

4,277 30th of 2000 higher than 1,971 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05543616 · 4,292 participants · Phase 2

    A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

  • NCT05774951 · 4,300 participants · Phase 3

    A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

  • NCT06492616 · 4,220 participants · Phase 3

    A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • NCT05910567 · 4,346 participants · NA

    A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03902431, the US trial registry maintained by the National Library of Medicine. NCT03902431 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.